Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Investors
Investor Welcome
ASX Announcements
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
30-Jan-2023
Quarterly Activities Report and Appendix 4C
18-Jan-2023
Collaboration with Walter Reed and UNSW Extended to 2025
16-Jan-2023
Notification of cessation of securities - NYR
11-Jan-2023
Brain Injury Program Update
21-Nov-2022
Results of Meeting
21-Nov-2022
AGM Presentation by James Bonnar CEO
21-Nov-2022
Nyrada AGM 2022 Chairmans Address
18-Nov-2022
Nyrada Receives A$1.2M R&D Tax Incentive Rebate
27-Oct-2022
CEO Remuneration Update
26-Oct-2022
Quarterly Activities Report and Appendix 4C
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next